Frei H, Thurneysen A
Spezialarzt FMH für Kinder und Jugendliche, FA Homöopathie SVHA, Laupen, Switzerland.
Br Homeopath J. 2001 Oct;90(4):183-8. doi: 10.1054/homp.1999.0506.
The sharp increase of the prescription of methylphenidate (MPD) in hyperactive children in recent years is a matter of increasing uneasiness among professionals, parents and politicians. There is little awareness of treatment alternatives. The purpose of this prospective trial was to assess the efficacy of homeopathy in hyperactive patients and to compare it MPD. The study was performed in a paediatric practice with conventional and homeopathic backgrounds. Children aged 3-17 y, conforming to the DSM-IV criteria for attention deficit hyperactivity disorder (ADHD) with a Conners Global Index (CGI) of 14 or higher were eligible for the study. All of them received an individual homeopathic treatment. When clinical improvement reached 50%, the parents were asked to reevaluate the symptoms. Those who did not improve sufficiently on homeopathy were changed to MPD, and again evaluated after 3 months. One hundred and fifteen children (92 boys, 23 girls) with a mean age of 8.3 y at diagnosis were included in the study. Prior to treatment the mean CGI was 20.63 (14-30), the mean index of the homeopathy group 20.52 and of the MPD-group 20.94. After an average treatment time of 3.5 months 86 children (75%) had responded to homeopathy, reaching a clinical improvement rating of 73% and an amelioration of the CGI of 55%. Twenty-five children (22%) needed MPD; the average duration of homeopathic (pre-) treatment in this group was 22 months. Clinical improvement under MPD reached 65%, the lowering of the CGI 48%. Three children did not respond to homeopathy nor to MPD, and one left the study. In cases where treatment of a hyperactive child is not urgent, homeopathy is a valuable alternative to MPD. The reported results of homeopathic treatment appear to be similar to the effects of MPD. Only children who did not reach the high level of sensory integration for school had to be changed to MPD. In preschoolers, homeopathy appears a particularly useful treatment for ADHD.
近年来，治疗多动症儿童的哌甲酯（MPD）处方急剧增加，这一现象日益引起专业人士、家长和政界人士的不安。人们对其他治疗方法知之甚少。这项前瞻性试验的目的是评估顺势疗法对多动症患者的疗效，并与MPD进行比较。该研究在一家具有传统医学和顺势疗法背景的儿科诊所进行。年龄在3至17岁、符合美国精神疾病诊断与统计手册第四版（DSM-IV）注意力缺陷多动障碍（ADHD）标准且康纳斯全球指数（CGI）为14或更高的儿童符合该研究的条件。他们全部接受了个体化的顺势疗法治疗。当临床改善达到50%时，要求家长重新评估症状。那些接受顺势疗法后改善不充分的儿童改为服用MPD，并在3个月后再次进行评估。115名诊断时平均年龄为8.3岁的儿童（92名男孩，23名女孩）被纳入该研究。治疗前，平均CGI为20.63（14 - 30），顺势疗法组的平均指数为20.52，MPD组为20.94。经过平均3.5个月的治疗，86名儿童（75%）对顺势疗法有反应，临床改善率达到73%，CGI改善了55%。25名儿童（22%）需要服用MPD；该组顺势疗法（预）治疗的平均持续时间为22个月。MPD治疗后的临床改善率达到65%，CGI降低了48%。3名儿童对顺势疗法和MPD均无反应，1名儿童退出了研究。在多动症儿童治疗不紧急的情况下，顺势疗法是MPD的一种有价值的替代方法。所报告的顺势疗法治疗结果似乎与MPD的效果相似。只有那些未达到学校所需的高度感觉统合水平的儿童才不得不改为服用MPD。在学龄前儿童中，顺势疗法似乎是治疗ADHD特别有用的方法。
